Director of Clinical Proton Physics Operations (Proton Therapy)

Location: Boston, Massachusetts, United States; hybrid with 2–3 days onsite per week

Salary: $140,000–$337,500 per year

Company

hirify.global is a cancer research and patient-care institution focused on cancer treatment, groundbreaking research, medical education, and public health.

What you will do

• Lead day-to-day clinical proton physics operations for an advanced proton radiation therapy program.
• Direct treatment planning workflows, patient positioning and immobilization, upright CT image guidance, and clinical protocol optimization.
• Oversee machine and patient-specific quality assurance, daily clinical coverage, staffing, and clinical physics team operations.
• Review and approve complex proton treatment plans and lead incident learning, root-cause analysis, and corrective actions.
• Coordinate with radiation oncologists, physicists, dosimetrists, therapists, engineers, and vendors to ensure accurate dose delivery and efficient clinical throughput.
• Lead acceptance testing, commissioning, recalibration, maintenance oversight, regulatory compliance, resource planning, and long-term proton program strategy.

Requirements

• PhD or equivalent in medical physics or a related field.
• ABR certification or equivalent.
• Substantial hands-on experience in clinical proton therapy operations.
• Strong experience with pencil-beam scanning systems and leadership of complex clinical workflows.
• Ability to work onsite in Boston 2–3 days per week.

Nice to have

• Experience with fixed-beam systems, novel patient positioning paradigms, or advanced image-guided proton therapy.
• Academic accomplishments supporting an appointment at Harvard Medical School at the Assistant or Associate Professor level.

Culture & Benefits

• Work in an innovative, inclusive, diverse, and equitable cancer-care environment.
• Opportunity to lead a pioneering proton therapy program at a leading cancer center.
• Opportunity to advance research, development, teaching, and innovative treatment paradigms.
• Potential academic appointment at Harvard Medical School, pending final approval.